Antibiotic Resistance Hoops Countered by Gene Drive Feedback Loops
CRISPR cut-and-insert mechanism boosts efficiency of gene drive targeting antibiotic resistance genes
Related Articles
Scratch That? De Novo Antibody Design Enters the AI Drug Discovery Toolbox
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the clinic faster.
Prime Medicine Chops 25% of Workforce, Pivots Pipeline as CEO Quits
Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime editing-based pipeline focus to liver disease and…
ASGCT 2025: Gates Foundation “Doubling Down” on HIV Cure
Mike McCune said the Gates Foundation is “doubling down” on finding a cure for HIV during an ASGCT symposium.
The News from New Orleans: GEN’s Takeaways from ASGCT
Kevin Davies and Julianna LeMieux chat about news from the ASGCT meeting live from the conference floor.
Ready to Drive Cell Therapy Success? Here Are the Keys.
Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations for helping you navigate cell therapy…
Strategies for Implementing and Optimizing Informatics and AI for Drug Discovery
In this GEN webinar, three informatics experts discuss how modern informatics platforms and AI technologies can restructure drug research and development workflows in academic labs…
3PBIOVIAN Introduces Two Platforms for AAV and pDNA Manufacturing
In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.
StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A
BioMarin agreed to shell out approximately $270 million for Inozyme Pharma, a developer whose treatments target the PPi-adenosine pathway, a key regulator of bone health…
Breaking the Bottleneck: On-Demand Biology in the Age of AI
© 2025 Mary Ann Liebert, Inc. Publishers. All rights reserved.
EvoCAST Harnesses CRISPR-Linked Bacterial Transposes to Insert Genes Into Human Cells
This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.